Isoniazid prophylaxis against tuberculosis in children

New England Journal of Medicine

Volumn 365, Issue 16, 2011, Pages 1543-1544

  Zar, Heather J ^a   Lombard, Carl ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b Institute for Biostatistics   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID;

CHILD CARE; CHILD HEALTH; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LETTER; LUNG TUBERCULOSIS; MORTALITY; PATIENT CARE; PRIORITY JOURNAL; PUBLIC HEALTH; TUBERCULOSIS CONTROL;

EID: 80054717685     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1109603     Document Type: Letter

References (3)

1. Madhi SA, Nachman S, Violari A, et al. Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. N Engl J Med 2011;365:21-31.
2. Zar HJ, Cotton MF, Strauss S, et al. Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial. BMJ 2007;334:136-43.
3. Frigati LJ, Kranzer K, Cotton MF, Schaaf HS, Lombard CJ, Zar HJ. The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting. Thorax 2011;66:496-501.